The latest pregnant women living with hiv antiretroviral therapy coverage for pmtct data in the Ivory Coast reports 80%, an decrease of 4% (-4.8%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in the Ivory Coast
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to the Ivory Coast
PMTCT antiretroviral therapy coverage
More indicators for the Ivory Coast
Male unintentional poisoning
3.3
-0.1
(2019)
Female wasting in children
7.1%
+1.6%
(2021)
Female prevalence of HIV
0.8%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar61
-intl dollar3
(2021)
Birth registration
71.7%
+6.7%
(2016)
Contraceptive modern method prevalence
19.6%
+1.8%
(2020)
Ivory Coast PMTCT antiretroviral therapy coverage between 2000 and 2022
Period | PMTCT antiretroviral therapy coverage | Change |
---|---|---|
2022 | 80% | -4% |
2021 | 84% | +2% |
2020 | 82% | -4% |
2019 | 86% | -6% |
2018 | 92% | 0% |
2017 | 92% | +4% |
2016 | 88% | -1% |
2015 | 89% | +3% |
2014 | 86% | +12% |
2013 | 74% | +16% |
2012 | 58% | +14% |
2011 | 44% | -2% |
2010 | 46% | +4% |
2009 | 42% | +9% |
2008 | 33% | +16% |
2007 | 17% | +8% |
2006 | 9% | -6% |
2005 | 15% | +9% |
2004 | 6% | +2% |
2003 | 4% | +2% |
2002 | 2% | +1% |
2001 | 1% | +1% |
2000 | 0% |